内部人交易记录
董事基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Barry Richard, 董事. Director active across 2 companies, notably Sarepta Therapeutics, Inc.. Aggregated, 16 disclosures have been published. Breakdown: 8 buys · 0 sell. Total volume traded: €2.5m. History available since 7 March 2022. The latest transaction was disclosed on 20 November 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Barry Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
16,875 股Common StockSEC:0001193125-26-260245:0
150,000 股@ US$2.766.7% 占其流量Common StockSEC:0001437749-25-036125:0
73,385 股@ US$2.753.5% 占其流量Common StockSEC:0001437749-25-035882:0
7,172 股@ US$2.280.3% 占其流量Common StockSEC:0001437749-25-029725:0
5,400 股@ US$2.130.2% 占其流量Common StockSEC:0001437749-25-029586:0
12,350 股@ US$32.6327.2% 占其流量Common StockSEC:0000950170-25-073954:0
9,746 股@ US$25.1816.6% 占其流量Common StockSEC:0000950170-25-071961:0
2,383 股0Common StockSEC:0000950170-25-037514:0
176,085 股@ US$22.0075.2% 占其流量Common StockSEC:0001437749-24-013144:0
1,846 股0Common StockSEC:0000950170-24-026615:0
10,000 股@ US$78.8156.2% 占其流量Common StockSEC:0001209191-23-054442:0
1,906 股@ US$16.800.6% 占其流量Common StockSEC:0001069530-23-000043:0
11,565 股@ US$26.135.9% 占其流量Common StockSEC:0001069530-23-000011:0
1,523 股0Common StockSEC:0001209191-23-017401:0
36,159 股@ US$23.7917.9% 占其流量Common StockSEC:0001069530-22-000041:0
2,953 股0Common StockSEC:0001209191-22-017348:0
About Barry Richard
Barry Richard is Administrateur and is associated with Sarepta Therapeutics, Inc. and Cassava Sciences INC. He has 16 filings in total, and across the 16 sampled filings, purchases total EUR 2475597 with no sales, from 2022-03-08 to 2026-06-05.